Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved parameters for risk estimation in Down's syndrome screening

H Cuckle1

  • 1Institute of Epidemiology and Health Services Research, Research School of Medicine, Leeds, U.K.

Prenatal Diagnosis
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change in prevalence of preterm birth in Israel following publication of national guidelines recommending routine sonographic cervical-length measurement at 19-25 weeks' gestation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Quality assessment of first-trimester screening for preterm pre-eclampsia.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Re: Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Early pregnancy prediction of spontaneous preterm birth before 32 completed weeks of pregnancy using plasma RNA: transcriptome discovery and initial validation of an RNA panel of markers.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

United States' experience in nuchal translucency measurement: variation according to provider characteristics in over five million ultrasound examinations.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Rethinking second-trimester Down-syndrome screening in the cell-free DNA era.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same journal

Genomic Landscape and Perinatal Outcomes of Fetal Polydactyly: A Retrospective Cohort Study Integrating CNV-seq and Trio-ES.

Prenatal diagnosis·2026
Same journal

Detecting Androgenetic Origin of the Genome via Single-Nucleotide Polymorphism-Based Cell-Free DNA Screening in Dichorionic Diamniotic Twin Pregnancies With Complete Hydatidiform Moles and a Coexisting Normal Fetus: A Three-Case Report.

Prenatal diagnosis·2026
Same journal

Structural Variation Sequencing of 26 Amniotic Fluid Samples With Partial Gene Duplications and Postnatal Follow-Up of the Fetuses.

Prenatal diagnosis·2026
Same journal

Prenatal Spectrum of COL2A1-Related Spondyloepiphyseal Dysplasia Congenita: A Review and Two Case Reports.

Prenatal diagnosis·2026
Same journal

Association of Fetal Cerebrovascular Resistance and Neurodevelopment in Congenital Heart Disease: A Physiology-Based Analysis.

Prenatal diagnosis·2026
Same journal

Prenatal Genetic Testing for Beckwith-Wiedemann Syndrome: Considerations, Challenges and Observations (A Real-World Study).

Prenatal diagnosis·2026
See all related articles

This study introduces a new method for calculating maternal serum marker distribution, enhancing Down's syndrome risk estimation. By combining local and meta-analysis data, it refines screening accuracy for pregnancies.

Area of Science:

  • Maternal-fetal medicine
  • Prenatal screening
  • Statistical genetics

Background:

  • Accurate risk estimation for Down's syndrome is crucial in prenatal screening.
  • Current methods may be limited by population-specific data.
  • Maternal serum markers require precise distribution parameter calculations for optimal performance.

Purpose of the Study:

  • To develop and validate a novel method for calculating maternal serum marker distribution parameters.
  • To improve the accuracy of Down's syndrome risk assessment in prenatal screening.
  • To integrate local population data with global meta-analysis findings.

Main Methods:

  • A hybrid approach combining local screened population data with meta-analysis of published studies.
  • Local data used to determine variance and covariance in unaffected pregnancies.

Related Experiment Videos

  • Meta-analysis used for mean levels in Down's syndrome pregnancies and differences in variance/covariance.

    • Main Results:

    • Analyzed 44 published studies, incorporating data from 6387 pregnancies.
    • Quantified mean levels and distribution differences for alpha-fetoprotein (AFP), unconjugated oestriol (uE3), human chorionic gonadotropin (hCG), and free beta-hCG.
    • Found increased variance for all markers and varied covariance patterns in Down's syndrome pregnancies compared to unaffected ones.

    Conclusions:

    • The proposed method enhances Down's syndrome risk estimation by utilizing comprehensive population data.
    • Integrating local and meta-analysis data provides more robust distribution parameters.
    • This refined approach offers improved accuracy for prenatal screening programs.